ArticleTranslational cancer research2021
Neuroendocrine tumor of thoracic spine: case report and literature review.
Article in Translational cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
- Cauda equina neuroendocrine tumour complicated by intra-tumoural hemorrhage in a young male: a case report and systematic review of the literature.Journal of spine surgery (Hong Kong) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neuroendocrine tumors (NETs) generally arise from endocrine cells of gut and bronchi. Primary NETs of spine are extremely rare and have been described in cervical spine, lumbar spine, sacrum, and coccyx. So far, primary NETs in thoracic spine have not been reported yet. Here we described a 46-year-old Chinese woman with NET in thoracic spine. Neuroimaging revealed a mass behind the vertebral body of T11, abnormal changes in the adnexa and surrounding soft tissue and compression of the spinal cord. She received a total resection of the tumor and T11 corpectomy. Histopathological examination and immunohistochemical staining proved the tumor to be a rare spinal NET. PET-CT and other examinations ruled out the existence of tumors in any other site. So, she was diagnosed with NET of thoracic spine. The patient received postoperative etoposide and nedaplatin chemotherapy for four cycles, and she recovered well with no evidence of tumor recurrence or metastasis during six-month medical follow-up. Spine location of NETs should be first considered as a metastatic disease unless there is proof ruling out the possibility. Complete tumor resection is the most effective therapy in NETs of spine and should be considered in priority, and chemotherapy and radiotherapy should be considered on an individual basis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.